Resources from the same session
266O - A population pharmacokinetic model: Assessment of pharmacokinetic similarity of HLX01 and rituximab in diffuse large B-cell lymphoma
Presenter: Yuankai Shi
Session: Mini Oral session - Haematological malignancies
Resources:
Abstract
270O - Imatinib induced toxicity and its influence on cytogenetic and molecular response in newly diagnosed patients with chronic myeloid leukemia
Presenter: Harivenkatesh Natarajan
Session: Mini Oral session - Haematological malignancies
Resources:
Abstract
LBA13 - Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
Presenter: Jun Ho Yi
Session: Mini Oral session - Haematological malignancies
Resources:
Abstract
Slides
267O - Treatment outcome for gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter Pylori negative
Presenter: Sung-Nam Lim
Session: Mini Oral session - Haematological malignancies
Resources:
Abstract
268O - Genetic variations in hematopoietic and mesenchymal stem cells in de novo myelodysplastic syndromes
Presenter: Manoj Bandara
Session: Mini Oral session - Haematological malignancies
Resources:
Abstract